Post-transplant multiple myeloma in a pediatric renal transplant patient

Pediatric Blood and Cancer

Volumn 47, Issue 2, 2006, Pages 218-223

  Tcheng, Wendy Y ^a,d   Said, Jonathan ^b   Hall, Theodore ^b   Al Akash, Samhar ^b   Malogolowkin, Marcio ^c   Feig, Stephen A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Epstein Barr virus; Multiple myeloma; Post transplant lymphoproliferative disease

Indexed keywords

ADOLESCENT; ARTICLE; CASE REPORT; CONGENITAL NEPHROTIC SYNDROME; DISEASE ASSOCIATION; DISEASE COURSE; EPSTEIN BARR VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MULTIPLE MYELOMA; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

ADOLESCENT; HEART TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; MULTIPLE MYELOMA;

EID: 33745773468     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20482     Document Type: Article

References (33)

1. Penn I. Tumor incidence in human allograft recipients. Transplant Proc 1979;11:1047-1051.
2. Penn I. Cancers complicating organ transplantation. N Engl J Med 1990;323:1767-1769.
3. Penn I. Neoplastic complications of organ transplantation. In: Ginns LC, Cosimi AB, Morris PJ, editors. Transplantation. Cambridge: Blackwell; 1998.
4. Frizzera G. Atypical lymphoproliferative disorders. In: Knowles DM, editor. Neoplastic hematopathology. Baltimore: Williams and Wilkins; 1992. 459p.
5. Reyes J, Green M, Bueno J, et al. Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation. Transplant Proc 1996;28:2768.
6. Hanto DW, Frizzera G, Purtillo DT, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 1981;41: 4253-4261.
7. Penn I. De novo malignancy in pediatric organ transplant recipients. J Pediatr Surg 1994;29:221-226.
8. Swinnen LJ. Treatment of organ transplant-related lymphoma. Hematol Oncol Clin North Am 1997;11:963-973.
9. Boubenider S. Hiesse C, Goupy C, et al. Incidence and consequences of post-transplantation lymphoproliferative disorders. J Nephrol 1997;10:136-145.
10. Nalesnik MA. Posttransplantation lymphoproliferative disorders (PTLD): Current perspectives. Semin Thorac Cardiovasc Surg 1996;8:139-148.
11. Basgoz N, Preiksaitis JK. Post-transplant lymphoproliferative disorder. Infect Dis Clin North Am 1995;9:901-923.
12. Nalesnik MA, Starzl TE. Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci 1994;4:61-79.
13. Sheil AGR, Flavel S, Disney APS, Mathew TH. Cancer in dialysis and transplant patients. Transplant Proc 1985;17:195-198.
14. Radl J, Valentijn RM, Haaijman JJ, et al. Monoclonal gammapathies in patients undergoing immunosuppressive treatment after renal transplantation. Clin Immunol Immunopath 1985;37:98-102.
15. Melato M, Paladini G. Multiple myeloma following reactivated epstein-barr virus infection in a renal-transplant recipient. Haematologica 1986;71:241-243.
16. Howard AD, Moore J, Tomaszeski MM. Occurrence of multiple myeloma three years after successful renal transplantation. Am J Kid Dis 1987;10:147-150.
17. Berthelemy C, Mourad G, Bataille R, et al. Survenue d'un myelome multiple 5 ans apres transplantation renale. Presse Medicale 1988; 17:1706.
18. Aparicio M, de Precigout V, Reiffers J, et al. Multiple myeloma and AL amyloidosis in a renal transplant recipient. Nephron 1989;53: 373-375.
19. Armitage JM, Kormos RL, Stuart R, et al. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 1991;10:877-887.
20. Bowen PA, Caruana RJ, Pantazis CG, et al. Asecretory myeloma in a renal transplant recipient. Clin Transplant 1991;5:408-410.
21. Brown JH, Newstead CG, Jos V, et al. Multiple myeloma in a renal transplant recipient. Nephrol Dial Transplant 1992;7:447-449.
22. Guerci AP, Burtin P, Mattel S, et al. Syndromes lymphoprolifertifs après transplantation cardiaque et traitemant par ciclosporine: A propos de 4 observations. Ann Med Interne (Paris) 1992;143:155-159.
23. Chucrallah AE, Crow MK, Rice LE, et al. Multiple myeloma after cardiac transplantation: An unusual form of posttransplant lymphoproliferative disorder. Human Pathol 1994;25:541-545.
24. Fischer T, Miller M, Bott-Silverman C, et al. Posttransplant lymphoproliferative disease after cardiac transplantation. Transplant 1996;62:1687-1690.
25. Leigh BR, Larkin EC, Scotte Doggett RL. Solitary extramedullary plasmacytoma five years after successful cardiac transplantation: Case report and review of the literature. Am J Clin Oncology 1997; 20:467-470.
26. Grey M, Townsend N, Lappin D, et al. IgA myeloma of donor origin arising 7 years after allogeneic renal transplant. Br J Haematol 2000;108:592-594.
27. Joseph G, Barker RL, Yuan B, et al. Posttransplantation plasma cell dyscrasias. Cancer 1994;74:1959.
28. Renoult E, Bertrand F, Kessler M. Monoclonal gammapathies in HbsAg-positi ve patients with renal transplants. N Engl J Med 1988; 318:1205.
29. Voelkerding KV, Sandhause LM, Kim HC, et al. Plasma cell malignancy in the acquired immune deficiency syndrome. Am J Clin Pathol 1989;92:222-228.
30. Grierson H, Purtilo DT. Epstein-Barr virus infection in males with the X-linked lymphoproliferative syndrome. Ann Intern Med 1987;106:538-545.
31. Penn I. Multiple myeloma in a renal transplant recipient. Am J Kidney Dis 1988;11:201.
32. Knowles DM, Chadburn A, Inghirami G. Immunophenotypic markers useful in the diagnosis and classification of hematopoietic neoplasms. In: Knowles DM, editor. Neoplastic hematopathology. Baltimore, MD: Williams & Wilkins; 1992. pp 91-93.
33. Matsui W, Huff CA, Wang Q, et al. Characterization of clonogenic multiple myeloma cells. Blood 2004;103:2332-2336.